BCLI - Brainstorm Cell Therapeutics Inc. Qarzning balans kapitallashuviga nisbati

Brainstorm Cell Therapeutics Inc. (BCLI) tovar belgisi

Brainstorm Cell (BCLI) terapiyasining muvaffaqiyati biomateriallarning suyuq azotda nuqsonsiz tashilishiga bog'liq. GURU.Markets grafigidagi qarzning bozor kapitalizatsiyasiga nisbati moliyaviy barqarorlikni vizuallashtiradi, bunda 0.00 belgisi asosiy ko'rsatkich vazifasini o'taydi. O'sish istiqbollari ALS ni davolash bo'yicha NurOwn sinovlari bilan belgilanadi, biroq hujayralarni qo'lda ishlab chiqarishning yuqori xarajatlari kompaniyaning daromadlarini kengaytirish qobiliyatini jiddiy ravishda cheklaydi.

BrainStorm Cell Therapeutics Inc. (BCLI) - Balans qiymatiga qarzlar 04.07.2022dan 02.08.2025gacha

Brainstorm Cell Therapeutics Inc. (BCLI) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Brainstorm Cell|BCLI - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati BrainStorm Cell Therapeutics Inc.|BCLI - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar BrainStorm Cell Therapeutics|BCLI - Kompaniyaning xususiy kapitali|Bozor kapitallashuvining balans qiymatiga nisbati brainstorm-cell.com|BCLI - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Brainstorm Cell|BCLI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Brainstorm Cell Therapeutics, Inc.|BCLI - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar BrainStorm Cell Therapeutics Inc.
Kompaniyaning fundamental tahlili:Brainstorm Cell
Brainstorm Cell Therapeutics Inc. asosiy tovari

Ushbu ko'rsatkich balans hisobotidagi umumiy majburiyatlarning kapitalga nisbatini o'lchab, moliyaviy leveraj darajasini aniqlaydi. Investorlar ushbu metrikadan to'lov qobiliyati risklarini va kapital tuzilmasining barqarorligini baholash uchun foydalanadilar. Joriy balans leveraj ko'rsatkichini tahlil qilish orqali qarz moliyalashtirish samaradorligini baholash mumkin. Brainstorm Cell (BCLI) uchun qarz yuklamasining pastligi juda muhimdir, chunki kompaniya aksiyalar opsionlari orqali noyob ilmiy iste'dodlarni saqlab qolishga e'tibor qaratadi. Ushbu ko'rsatkichning barqarorligi firma kreditorlar tomonidan ortiqcha bosimsiz klinik sinovlarni moliyalashtirish qobiliyatini tasdiqlaydi.

Brainstorm Cell kimlar bilan raqobatlashadi

Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|Xenon Corp (XENE) - Balans qiymatiga qarzlar|Balans kapitallashuviga qarzlar Viking Therapeutics|Qarzning balans kapitallashuviga nisbati SUPN|Catalyst Pharmaceuticals, Inc. (CPRX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Denali (DNLI)|Balans kapitallashuviga qarzlar HRMY (Harmony Pharma)|Balans kapitallashuviga qarzlar Biohaven Corp BHVN|Balans kapitallashuviga qarzlar AMLX (Amylyx Pharmaceuticals)|TRVI: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Praxis Precision Medicines, Inc.|AVXL (Anavex) - Qarzning balans qiymatiga nisbati|CBLL: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar prothena.com (PRTA)|Qarzning balans qiymatiga nisbati Alector, Inc.|Qarzning balans kapitaliga nisbati ANNX (annexonbio.com)|OMER: Qarzning balans kapitallashuviga nisbati|Neurogene Inc - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati AC Immune Corp (ACIU)|VYGR: Qarzning sof aktivlarga nisbati|NMRA (Neumora Therapeutics) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati scilexholding.com|TVGN - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Alpha Cognition Corp|Balans kapitallashuviga qarzlar CGTX (Cognition Therapeutics)|Qarzning balans qiymatiga nisbati Inhibikase Pharma (IKT)|SAVA: Balans kapitallashuviga qarzlar|Assertio Holdings - Balans qiymatiga qarzlar|COYA - Qarzning balans kapitallashuviga nisbati|VTGN: Qarzning balans kapitallashuviga nisbati|ovidrx.com (OVID) - Qarzning balans kapitallashuviga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar CervoMed Inc.|Qarzning balans kapitallashuviga nisbati Alterity Therapeutics Ltd|Balans kapitallashuviga qarzlar CLNN (Clene Inc.)|Qarzning balans qiymatiga nisbati PEPG (pepgen.com)|Qarzning balans kapitallashuviga nisbati Jupiter Neurosciences Inc JUNS|Qarzning balans kapitallashuviga nisbati Relmada Corp RLMD|Balans kapitallashuviga qarzlar ANVS (Annovis Bio, Inc.)|GRCE: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Firefly Neuroscience|Klotho Neurosciences (KLTO) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar NRSN (NeuroSense Therapeutics Ltd)|Balans qiymatiga qarzlar Reviva Pharmaceuticals, Inc. (RVPH)|Qarzning balans qiymatiga nisbati MTVA|Balans kapitallashuviga qarzlar NRXS (neuraxis.com)|Qarzning balans kapitallashuviga nisbati Helius Medical Technologies|Passage Bio Inc. - Qarzning sof aktivlarga nisbati|NEUP (Neuphoria) - Qarzning balans kapitallashuviga nisbati|NERV - Balans qiymatiga qarzlar|Athira Pharma, Inc. (ATHA) - Balans kapitallashuviga qarzlar|ADXN (addextherapeutics.com) - Qarzning balans kapitallashuviga nisbati|ALZN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Cyclerion|Balans kapitallashuviga qarzlar PTIX|Balans kapitallashuviga qarzlar pasitheaclinics.com (KTTA)|Balans kapitallashuviga qarzlar CRGT|avenuetx.com - Sof aktivlarga qarzlar|Cara Therapeutics (CARA) - Qarzning balans kapitallashuviga nisbati|CHRO: Qarzning balans qiymatiga nisbati|eliemtx.com - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Intra-Cellular Therapies, Inc.|Longboard Pharmaceuticals (LBPH) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati MRNS|NKGen Biotech - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar NRBO (NeuroBo Pharmaceuticals Inc)|Qarzning balans kapitallashuviga nisbati Sage Therapeutics, Inc|Synaptogenix, Inc - Qarzning sof aktivlarga nisbati|TRVN: Qarzning balans kapitallashuviga nisbati|Vigil Neuroscience (VIGL) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Anew Medical WENA|Cerevel Therapeutics Inc (CERE) - Qarzning sof aktivlarga nisbati